Lectins are natural bioactive ubiquitous proteins or glycoproteins of non-immune response that bind reversibly to glycans of glycoproteins, glycolipids and polysaccharides possessing at least one non-catalytic domain causing agglutination. Some of them consist of several carbohydrate-binding domains which endow them with the properties of cell agglutination or precipitation of glycoconjugates. Lectins are rampant in nature from plants, animals and microorganisms. Among microorganisms, algae are the potent source of lectins with unique properties specifically from red algae. The demand of peculiar and neoteric biologically active substances has intensified the developments on isolation and biomedical applications of new algal lectins. Comprehensively, algal lectins are used in biomedical research for antiviral, antinociceptive, anti-inflammatory, anti-tumor activities, etc. and in pharmaceutics for the fabrication of cost-effective protein expression systems and nutraceutics. In this review, an attempt has been made to collate the information on various biomedical applications of algal lectins.
In the present study, ten Fusarium sp. were screened for the presence of lectins by hemagglutination assay using human and animal erythrocytes. Amongst them nine species, namely F. acuminatum, F. chlamydosporium, F. coeruleum, F. compactum, F. concolor, F. crookwellense, F. culmorum, F. decemcellulare and F. dimerum were found to possess lectin activity. Neuraminidase treatment to rabbit erythrocytes considerably augmented hemagglutination titre, but no such effect was observed with protease-treated erythrocytes. Lectins were tested for inhibition of hemagglutination activity against a panel of carbohydrates. Majority of the lectins were inhibited by L-fucose, D-galactose, bovine submaxillary mucin and dextran. γ-Globulin was inhibitory against lectins from F. acuminatum, F. chlamydosporium, F. compactum and F. culmorum at a concentration of >250 µg/mL, whereas bovine submaxillary mucin and porcine stomach mucin were observed to be strongest inhibitors of lectin from F. compactum with minimum inhibitory concentration of 7.18 µg/mL and 15.6 µg/mL, respectively. Most of the lectins displayed antimicrobial activity against Bacillus cereus, Escherichia coli, Staphylococcus aureus and Aspergillus niger. Lectins from F. chlamydosporium, F. culmorum and F. crookwellense have also exhibited antimicrobial activity against Candida albicans. These findings illustrate the significance of Fusarium sp. lectins in clinical applications.
In the present study, antibacterial and anticancerous drug loading kinetics for the (10-x)CuO-xZnO-20CaO-60SiO-10PO (2≤x≤8, varying in steps of 2) mesoporous bioactive glasses (MBGs) have been studied. XRD analysis of the as prepared glass samples proved its amorphous nature. Scanning electron microscopy (SEM) revealed the apatite layer formation on the surface of the MBGs after soaking for 15 days in SBF. Ion dissolution studies of calcium, phosphorous and silicon have been performed using inductively coupled plasma (ICP). FTIR and Raman analysis depicted about the presence of various bonds and groups present in the glasses. The pore size of MBGs lies in the range of 4.2-9.7 nm. Apart from this, specific surface area of the MBGs varied from 263 to 402 cm/g. The MBGs were loaded with Doxorubicin (DOX), Vancomycin (VANCO) and Tetracycline (TETRA) drugs among which, the decreasing copper content influenced the loading properties of doxorubicin and tetracycline drugs. Vancomycin was fully loaded almost in all the MBGs, whereas other drugs depicted varying loading with respect to the copper content.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.